Laparoscopic Italian Experience with the Lap-Band&lt;SUP&gt;®&lt;/SUP&gt;

Angrisani, Luigi; Alkilani, M.; Basso, Nicola; Belvederesi, N.; Campanile, Fabio Cesare; Capizzi, Francesco Domenico; D'atri, C.; Cosmo, L. Di; Doldi, S B; Favretti, Franco; Forestieri, Pietro; Furbetta, Francesco; Giacomelli, F; Giardiello, Cristiano; Iuppa, A; Lesti, G.; Lucchese, Marcello; Puglisi, Francesco; Scipioni, L; Toppino, M; Turicchia, Giorgio Ubaldo; Veneziani, A; Docimo, C; Borrelli, Vincenzo; Lorenzo, Michele

doi:10.1381/096089201321336656

Cited by 93 publications

(41 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In several large series (2 with Ͼ700 patients each) from Belgium [36], Italy [37], and Australia [35], mortality rates of 0% to 0.1% were reported. However, an Italian multicenter study of 1,265 patients reported a postoperative mortality of 0.55% (7 deaths, but only 2 reported occurring within 30 days of surgery) [38]. Major complications are uncommon, with band slippage (2.2% to 10%) [37][38][39], port complications (1% to 11%) [34,37], and band erosion (0.3% to 1.9%) [38 -40] the most frequently reported complications that may require reoperation [35][36][37][38].…”

Section: Gastric Banding Resultsmentioning

confidence: 99%

Medical and surgical options in the treatment of severe obesity

Fisher

Schauer

2002

The American Journal of Surgery

275

156

View full text Add to dashboard Cite

Weight loss programs, diets, and drug therapy have not shown long-term effectiveness in treating morbid obesity. A 1992 statement from the National Institutes of Health Consensus Development Conference affirmed the superiority of surgical over nonsurgical approaches to this condition. Bariatric surgical procedures work in 1 of 2 ways: by restricting a patient's ability to eat (restrictive procedures) or by interfering with ingested nutrient absorption (malabsorptive procedures). Many of these procedures can be performed by a laparoscopic approach, which has been shown to reduce operative morbidity. In the United States, the primary operative choice for morbidly obese patients has recently shifted from vertical banded gastroplasty (VBG) to the Roux-en-Y gastric bypass (RYGBP). VBG, a purely restrictive procedure, has fallen into disfavor because of inadequate long-term weight loss. RYGBP combines restriction and malabsorption principles, and has been shown to induce greater weight loss than VBG. Other procedures currently being offered include laparoscopic adjustable gastric banding; biliopancreatic diversion (BPD), including the duodenal switch (BPD-DS) variation; and distal gastric bypass (DGBP). The problem of obesity has reached epidemic proportions in the United States. More than 50% of adults are obese or overweight, and 5% are severely obese (body mass index [BMI] of Ն35) [1]. Numerous studies have demonstrated a strong relation between BMI and the development of lifeimpairing comorbidities, such as hypertension, diabetes (type 2), atherosclerosis, sleep apnea, and osteoarthritis. Obesity is associated with a higher risk of cancer (breast, colon, uterine) and premature death. Patients with severe or morbid obesity (BMI Ͼ35), the focus of this review, are consequently most severely affected by the disease, have a poor quality of life, and thus have the greatest need for weight loss therapy. Numerous medical and surgical treatments for severe obesity have come and gone over the years, underscoring the challenge and complexity of obesity management. The intent of this review is to summarize the current status of medical and surgical options for the treatment of severe obesity. Management of obesity

show abstract

Section: Gastric Banding Resultsmentioning

confidence: 99%

Medical and surgical options in the treatment of severe obesity

Fisher

Schauer

2002

The American Journal of Surgery

275

156

View full text Add to dashboard Cite

show abstract

“…We suggest that it could be explained by the length of follow-up and the type of routine studies done during follow-up in each study. It seems that the band erosion can be a clinically silent event in a sizeable proportion of cases [2,10], but that it may be detected early by a routine endoscopy. The studies that report on a high rate of intragastric band migration performed gastroscopy as an integral part of their follow-up.…”

Section: Discussionmentioning

confidence: 99%

The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity

et al. 2003

View full text Add to dashboard Cite

show abstract

“…Outside of the United States, laparoscopic gastric banding has been shown to be a very effective weight-loss procedure [1,2,4,6,15,30,31,37]. The technique has been modified during the past 8 years.…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic adjustable gastric banding for massive superobesity ( > 60 body mass index kg/m 2 )

Fielding¹

2003

Surgical Endoscopy

View full text Add to dashboard Cite

Surgery for massive super obesity is a formidable challenge. No existing open or laparoscopic procedure reduces BMI below 30 from a starting point above 55. Laparoscopic adjustable gastric banding has been used to treat 76 massive super obese patients with a BMI > 60 kgs/m2. Median weight was 193 kgs +/-34.7 kgs (154-335 kgs). Five patients had a BMI > 100 kgs/m2. There was neither mortality nor pulmonary emboli. hospital stay was 3 days (1-6 days). Excess weight loss was 46.69 +/-10.5 at 1 year; 59.14 +/- 11.7% at 3 years and 61 +/- 15.1% at 5 years. At 2 years, 84% of the patients had greater than 50% excess weight loss and this was maintained at 3, 4, and 5 years. BMI fell from 69 +/- 6.2 to 49 +/- 7.73 at 1 year to 37 +/- 4.45 at 3 years and this was maintained at 4 and 5 years. BMI in 13 patients with > 5 year follow up was 35.09 +/- 53 kgs/m2 (27-44). Weight loss with laparoscopic adjustable gastric banding in this group of massive super obese patients has been similar to all other surgical techniques with reduction of BMI from 69 to 33 kgs/m2 at 3 years. The relative safety of the Lapband avoids bowel surgery in these very big patients, suggesting that laparoscopic adjustable gastric banding is a valid surgical approach to these difficult patients.

show abstract

Laparoscopic Italian Experience with the Lap-Band<SUP>®</SUP>

Abstract: The LASGB operation is safe and effective, and deserves wider use for treatment of morbid obesity.

Cited by 93 publications

References 9 publications

Medical and surgical options in the treatment of severe obesity

Medical and surgical options in the treatment of severe obesity

The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity

Laparoscopic adjustable gastric banding for massive superobesity ( > 60 body mass index kg/m 2 )

Contact Info

Product

Resources

About